Shift-work disorderThe diagnosis of SWD is particularly challengingbecause its defining symptoms of ES and/or insomniaare demonstrated by numerous morbidities, includingother sleep disorders. Furthermore, normal andabnormal responses to the challenge of shift work arenot easily differentiated, and current diagnostic criteriarequire additional validation. 3 Identification of SWDrelies on detailed discussion of a patient’s medical history,knowledge of relevant risk factors, and differentialdiagnosis to rule out other potentially causative medicalconditions. Dr Jonathan Schwartz provides a <strong>com</strong>prehensiveguide to recognizing and diagnosing patientswith SWD in the third article of this supplement. In thefinal article, Dr Michael Thorpy discusses the behavioraland pharmacologic options available for patients withSWD in order to address ES and insomnia as well as <strong>com</strong>orbidities.He also supplies a useful algorithm to assistwith the treatment of SWD in the primary care setting.Epidemiology of SWD, insomnia,and ES in shift workersFor approximately 22 million US adults, shift work is anintegral part of their professional life. 4 Of these individuals,about 3.8 million regularly work night shifts, and anadditional 3.3 million perform night-shift work on a rotatingbasis. 5Drake and colleagues 6 used a telephone questionnaireto conduct a study of the prevalence of SWD in thegeneral population of Detroit, MI; 2036 day-shift, 360rotating-shift, and 174 night-shift workers participated.This study used minimum International Classificationof Sleep Disorders 2 (ICSD–2) criteria to define SWD 1 ;namely, subjects with ES and/or insomnia who had beenworking either a night-shift or a rotating-shift schedulefor the past 2 weeks were diagnosed with SWD. In thisstudy, ES was defined by an Epworth Sleepiness Scale(ESS) 7 score of the total sample mean + 1 standard deviation(effectively, an ESS score of ≥13, <strong>com</strong>pared withthe more <strong>com</strong>monly applied ES diagnostic score of ≥10).Insomnia was diagnosed using Diagnostic and StatisticalManual of Mental Disorders, Fourth Edition, Text Revisioncriteria, 8 ie, the subject had experienced periodicrecurrences of difficulty in falling asleep, staying asleep,or nonrestorative sleep for at least 1 month, with a selfreportedseverity of at least 6 points out of a possiblescore of 10 on a visual analog scale.Drake and colleagues 6 reported that 32.1% and26.1% of night-shift and rotating-shift workers, respectively,met their prespecified ES and/or insomnia criteria,<strong>com</strong>pared with 18.0% of day workers. The differential“true” prevalence of ES and insomnia—and thereforeSWD—in night-shift and rotating-shift workers was reportedto be approximately 14.1% and 8.1%, respectively.When it is considered that approximately 6% of allworkers in the United States perform night- or rotatingshiftwork, the overall prevalence of SWD in the generalpopulation was estimated to be approximately 1%. 6 Thisresult is lower than the 2% to 5% estimated in the ICSD–2coding manual, 1 and some sleep specialists have arguedthat the figure put forward by Drake and colleagues 6 isconservative. 3 However, Drake and colleagues 6 also appliedthe more usual ES diagnostic measure of an ESSscore of ≥10 and, using this criterion, found a muchhigher prevalence of ES in their study population: 44.8%of night-shift workers and 35.8% of rotating-shift workerswere found to have ES and therefore would also beconsidered to have SWD, provided their symptoms persistedfor ≥1 month.A recent study of 4471 US police officers reportedthat 2.0% of this population had SWD, which was definedby the occurrence of both insomnia and ES in associationwith a recurrent schedule of work that overlappedthe normal rest period. 9Epidemiologic data for SWD are sparse and additionalstudies are warranted. Few overt data exist for theprevalence of SWD. Although the occurrence of insomniaand/or ES has been studied in various shift-workingpopulations, frequently only one symptom is analyzed.Shift-working individuals who have either symptom for≥1 month should be regarded as meeting the diagnosticcriteria for SWD even if this is not stated explicitly by therespective study investigators.For example, the Helsinki Heart Study examinedthe occurrence of insomnia and/or ES over a 3-monthperiod in a population of approximately 3000 middleagedmen participating in a coronary heart diseaseprevention trial. 10 Persistent insomnia was reported byapproximately 50% of rotating- and night-shift workers,whereas persistent ES was reported by approximately25% of shift workers overall; those with ES and/or insomniatherefore met the diagnostic criteria for SWD. 10By contrast, a study using the Multiple Sleep LatencyTest in a population of shift-working, long-haul busdrivers reported that the criteria for ES were met by 38%to 42% of subjects. 11 However, as the time frame overwhich patients experienced ES was not measured in thisstudy, these patients should be viewed as being at risk ofdeveloping SWD, as opposed to having SWD per se. 11Similarly, in a study of police officers, insomnia orhypersomnia were reported by a significantly higherproportion of shift-working personnel <strong>com</strong>pared withS January 2010 / Vol 59, No 1 • Supplement to The Journal of Family Practice
their day-working colleagues (insomnia, 25.9% vs 15.8%[P < .001]; hypersomnia, 4.9% vs 2.2% [P < .02]). 12 Theabsence of data regarding persistence of these symptomsprecludes diagnosis of SWD in these patients.Other studies have reported the prevalence of unplannednapping at work, which may be indicative ofES or sleep deprivation. For example, in a study of almost700 registered female nurses, approximately 35%and 32% of participants working rotating or night shifts,respectively, reported episodes of unplanned sleep atwork and may therefore have been at risk for developingSWD. 13Comorbidities associated withshift work and SWDThere are few reported studies regarding <strong>com</strong>orbiditiesin patients with SWD, although a large epidemiologicstudy has reported that patients with SWD are significantlymore likely to experience <strong>com</strong>orbidities than areday workers or shift workers without SWD (P < .05). 6Shift work has adverse effects on health even in the absenceof SWD, although to date there is no evidence thatshift work directly affects longevity. 14,15Metabolic disturbance and gastrointestinal issuesThe relationship between sleep disturbance and obesityis well documented but poorly understood due to its<strong>com</strong>plexity. 16 Sleep deprivation in particular has beenimplicated in the pathogenesis of weight gain and diabetes,and it may be that recognition and treatment ofsleep disorders in general may assist with curtailing thecurrent obesity epidemic. 17In a study of 500 male municipal workers in Italy, 3of the 5 diagnostic symptoms of metabolic syndrome—obesity, elevated cholesterol, and raised triglyceride levels—werefound significantly more frequently in nightshiftworkers than in day workers (P < .001, P < .01, andP < .001, respectively), indicating that shift work is associatedwith significant metabolic disturbance. 18 Thisreport extended the findings of an earlier study thatdemonstrated that shift workers at a chemical plant inItaly had a significantly higher mean body mass index(BMI) than their day-working colleagues (27.7 kg/m 2 vs26.5 kg/m 2 , respectively; P < .01). 19 In addition, the prevalenceof diabetes increased with duration of exposureto shift work, and markers of insulin resistance weremore <strong>com</strong>mon in shift workers than in day workers. 20,21Compared with day workers, shift workers alsohave higher rates of peptic ulcers and gastrointestinalproblems, such as constipation and diarrhea. 22,23 Thesefindings were confirmed by a large trial of US workers,which reported that night-shift workers (odds ratio[OR], 3.13; 95% confidence interval [CI], 1.62-6.05), rotating-shiftworkers (OR, 2.32; 95% CI, 1.32-4.06), andsubjects diagnosed with symptoms of SWD (OR, 4.55;95% CI, 2.47-8.37) experienced increased rates of pepticulcers <strong>com</strong>pared with day workers (P < .001 for all <strong>com</strong>parisons).6 Furthermore, both the effects of shift workand the symptoms of SWD contributed cumulatively tothe increased likelihood of developing an ulcer amongpatients with SWD. 6Metabolic disturbance and gastrointestinal symptomsin shift workers and patients with SWD may arisein response to eating at unusual times of day, as foodintake acts as a cue for the synchronization of the circadianclock. Moreover, gastric secretions in the middle ofthe night oppose the intrinsic circadian rhythm of enzymaticactivity set by the light/dark cycle. The increasedconsumption of caffeine and alcohol used as copingstrategies by many shift workers may also lead to gastrointestinalsequelae. 24Cardiovascular issuesHeart rate and blood pressure vary throughout the daydue to circadian control; however, persistent nocturnalactivity due to night work reportedly limits or abolishesthe normal nocturnal reductions in blood pressure anddecreases heart rate variability. 25,26 Individuals who donot experience circadian-driven fluctuations in bloodpressure are likely to develop hypertension, which maylead to further cardiovascular sequelae. 27 In addition,there is some evidence that ES may be a risk factor forhypertension. 28 Shift workers have a 40% increased riskof developing cardiovascular disease <strong>com</strong>pared withday workers. 29 Interestingly, a large study of the generalpopulation in Detroit, MI, reported that while nightshift(OR, 2.57; 95% CI, 1.24-5.30) and rotating-shiftwork (OR, 2.01; 95% CI, 1.06-3.83) were associated withan increased risk of heart disease (P = .01), the symptomsof SWD per se did not additionally exacerbateheart disease. 6 However, a cohort study of nearly 6000participants (the Cardiovascular Health Study) reportedthat ES is linked with increased rates of myocardialinfarction, total and cardiovascular mortality, and congestiveheart failure, 30 although differences between thestudy populations in this and the study by Drake andcolleagues 6 preclude direct <strong>com</strong>parison of their results.Changes in hormone secretion, autonomic andsympathetic cardiac control, metabolism, and heartrate while working at night are implicated in shift-workrelatedcardiovascular problems. 18,31 Other factors, suchSupplement to The Journal of Family Practice • Vol 59, No 1 / January 2010 S
- Page 1 and 2: Practice Management Tips ForSHIFT W
- Page 3 and 4: Patient QuestionnaireDo you often f
- Page 5 and 6: Sleep/Wake LogIn bedOut of bedLight
- Page 7 and 8: PHQ-9 QUICK DEPRESSION ASSESSMENTFo
- Page 9 and 10: Insomnia Severity IndexPlease answe
- Page 11 and 12: Take-Away PointsSHIFT WORK DISORDER
- Page 13 and 14: SHIFT WORKDISORDERBright Light Ther
- Page 40 and 41: PrimarycareScreeningfor depressioni
- Page 42 and 43: PrimarycareThescreening questionnai
- Page 44 and 45: Shift-work disorderContents and Fac
- Page 48 and 49: Shift-work disorderas heightened le
- Page 50 and 51: Shift-work disorderFigure 1 Risk ra
- Page 52 and 53: Shift-work disorderare not function
- Page 54 and 55: The characterization andpathology o
- Page 56 and 57: Shift-work disorderFigure 2 Sleep/w
- Page 58 and 59: Shift-work disorderFigure 3 Blood p
- Page 60 and 61: Recognition of shift-workdisorder i
- Page 62 and 63: Shift-work disorderThe timing of sh
- Page 64 and 65: Shift-work disorderthe other potent
- Page 66 and 67: Managing the patient withshift-work
- Page 68 and 69: Shift-work disorderFigure 3 Optimal
- Page 70 and 71: Shift-work disorderfor a motor vehi
- Page 72 and 73: Shift-work disordermoderate caffein
- Page 74 and 75: Supplement toAvailable at jfponline
- Page 76 and 77: Armodafinil for Treatment of Excess
- Page 78 and 79: Armodafinil for Treatment of Excess
- Page 80 and 81: Armodafinil for Treatment of Excess
- Page 82 and 83: Armodafinil for Treatment of Excess
- Page 84 and 85: Armodafinil for Treatment of Excess
- Page 86 and 87: Armodafinil for Treatment of Excess
- Page 88 and 89: Armodafinil for Treatment of Excess
- Page 90 and 91: Armodafinil for Treatment of Excess
- Page 92 and 93: Armodafinil for Treatment of Excess
- Page 94 and 95: Armodafinil for Treatment of Excess
- Page 96 and 97:
Armodafinil for Treatment of Excess
- Page 98 and 99:
The Epidemiology and Diagnosis of I
- Page 100 and 101:
The Epidemiology and Diagnosis of I
- Page 102 and 103:
The Epidemiology and Diagnosis of I
- Page 120 and 121:
CIRCADIAN RHYTHM SLEEP DISORDERSPra
- Page 122 and 123:
Table 2— AASM Levels of Recommend
- Page 124 and 125:
3.2.1.1 Both the Morningness-Evenin
- Page 126 and 127:
Five studies used one of the newer
- Page 128 and 129:
as an indicator of phase in sighted
- Page 130 and 131:
4.4 Advanced Sleep Phase DisorderBe
- Page 132 and 133:
45. Walsh, JK, Randazzo, AC, Stone,
- Page 134:
123. Van Someren, EJ, Kessler, A, M
- Page 142 and 143:
Table 1—Subject Demographicsn M:F
- Page 144 and 145:
Scale. 28 The simple reaction time
- Page 146 and 147:
Median RT (msec)1600A14001200100080
- Page 148 and 149:
10Mentally AExhaustedSharpScore8642
- Page 150 and 151:
Current Treatment Options in Neurol
- Page 152 and 153:
398 Sleep Disordersand sleep loss,
- Page 154 and 155:
400 Sleep DisordersTable 1. Treatme
- Page 156 and 157:
402 Sleep DisordersStandard dosageC
- Page 158 and 159:
404 Sleep DisordersStandard procedu
- Page 160 and 161:
406 Sleep DisordersCaffeineMelatoni
- Page 162 and 163:
408 Sleep DisordersWake-promoting a
- Page 164 and 165:
410 Sleep Disordersnight shift: ada